Your browser doesn't support javascript.
loading
Determinants of the efficacy of HIV latency-reversing agents and implications for drug and treatment design.
Ke, Ruian; Conway, Jessica M; Margolis, David M; Perelson, Alan S.
Affiliation
  • Ke R; Department of Mathematics, North Carolina State University, Raleigh, North Carolina, USA.
  • Conway JM; Theoretical Biology and Biophysics Group, MS-K710, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.
  • Margolis DM; Department of Mathematics and Center for Infectious Disease Dynamics, Pennsylvania State University, State College, Pennsylvania, USA.
  • Perelson AS; University of North Carolina (UNC) HIV Cure Center, UNC Institute of Global Health and Infectious Diseases.
JCI Insight ; 3(20)2018 10 18.
Article in En | MEDLINE | ID: mdl-30333308
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Virus Latency / Anti-HIV Agents / Models, Biological Type of study: Prognostic_studies Limits: Humans Language: En Journal: JCI Insight Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Virus Latency / Anti-HIV Agents / Models, Biological Type of study: Prognostic_studies Limits: Humans Language: En Journal: JCI Insight Year: 2018 Document type: Article Affiliation country: Country of publication: